multi-valent vaccine
Scope
Date
~
-
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
-
Airlines
Korean Air to showcase UAVs at ADEX 2023
Korean Air Lines Co. will participate in the "Seoul Aerospace & Defense Exhibition 2023" (ADEX 2023) taking place at Seoul Air Base in Seongnam,...
Oct 16, 2023 (Gmt+09:00)
-
Korean startups
TUNiB launches multi-persona AI chatbot DearMate
South Korean generative artificial intelligence (AI) startup TUNiB on Thursday announced the launch of DearMate, a mobile app for free conversatio...
Oct 13, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...
Oct 12, 2023 (Gmt+09:00)
-
Bio & Pharma
EuBiologics, GC Biopharma to jointly produce cholera vaccine
South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l marks 1st animal vaccine exports
POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
Aug 24, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom to enter generative AI market with large language model
SK Telecom announced on Wednesday that it will provide tailored generative AI services to businesses and public agencies using various advanced arti...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
Aug 21, 2023 (Gmt+09:00)
-
Artificial intelligence
SK invests $100 mn in ChatGPT developer's rival Anthropic
South Korea’s SK Telecom Co. said on Sunday it has invested $100 million in the US startup Anthropic, a ChatGPT rival artificial intelligence ...
Aug 13, 2023 (Gmt+09:00)
-
Banking & Finance
SK C&C begins to construct S.Korea's first ATS
SK C&C, an information and communications technology affiliate of South Korea’s SK Group announced on Wednesday it has started constructio...
Aug 02, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to make first domestic 6-in-1 vaccine for infants
South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience, Thai’s GPO to jointly boost vaccine infrastructure
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's SK Bioscience to resume domestic flu vaccine output
South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Economy
Seoul to lower bar for multi-child family subsidies to raise birth rate
The Seoul Metropolitan Government will change the definition of multi-child families from those with three or more kids younger than 13 to household...
May 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korea’s beauty brand Laneige enters UK, Middle East market
Amorepacific Corp.'s cosmetic brand Laneige announced on Tuesday that it is accelerating its global business expansion by entering the UK and Middle...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Steel
POSCO to supply steel to Samsung Electronics under long-term contract
POSCO Holdings Inc., the parent of South Korea’s top steelmaker, will supply steel to Samsung Electronics Co. under a long-term deal, which is...
Apr 25, 2023 (Gmt+09:00)
-
Cloud computing
Korea's LG CNS launches cloud cost optimization service
LG CNS, a South Korean company specializing in digital transformation, announced on Tuesday the launch of its new service called "FinOps" Clinic.Fin...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Mar 21, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Uplus offers foreign language chat service for customers
LG Uplus Corp., a South Korean telecom operator of LG Group, said on Tuesday that it had launched a foreign language chat service for its customers,...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's EuBiologics to receive support from Gates Foundation
South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...
Feb 23, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand